(Q44060951)

English

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

scientific article

Statements

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance? (English)
J Mezynski
C Pezaro
D Bianchini
E Thompson
E Sheridan
B Baikady
A Sarvadikar
G Maier
A H M Reid
A Mulick Cassidy
D Olmos
J de Bono
5 July 2012
2943-2947

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit